David Carl Humphrey - Feb 17, 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Signature
/s/ David Carl Humphrey
Stock symbol
ENSC
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 06:05 PM
Previous filing
Feb 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENSC Stock Option Award +80K 80K Feb 17, 2022 Common Stock 80K $1.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 17, 2022, Mr. Humphrey was granted an option (the "Stock Option") to purchase 80,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with an exercise price of $1.40. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 17, 2022 and the remainder in equal installments monthly for the thirty-six months thereafter.